Skip to content

To Evaluate The Efficacy Of Ropana Effect Of Priyangvadi Churna On Shuddha Vrana.

A Randomised Controlled Clinical Trial To Evaluate The Ropana Effect By Avachurnan Of Priyangvadi Churna On Shuddha Vrana - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094757
Enrollment
120
Registered
2025-09-15
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L989- Disorder of the skin and subcutaneous tissue, unspecified

Interventions

None listed

Sponsors

Dr Ruturaj Mohanrao Gaikwad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients irrespective of gender, economic class, caste, religion Patient having sign and symptoms of Shuddha Vrana having area less then length 5x 5 cm & max depth 5 mm will be randomly selected

Exclusion criteria

Exclusion criteria: Known cases of HIV, Hepatitis B, any systemic disease Dushta Vrana(Infected wounds) Diabetic ulcers Tubercular Ulcers Venous Ulcers Leprotic Ulcers Malignant Ulcers Burns Wounds having excessive loss of Tissues i.e.wound include bone,and tendon injury, exposed bone

Design outcomes

Primary

MeasureTime frame
Relief from symptoms and wound healingTimepoint: 15 days

Secondary

MeasureTime frame
Secondary outcome will be to determine whether the interventional drug is better than the controller drugTimepoint: 15 days

Countries

India

Contacts

Public ContactDr LAXMI MAROTI NARHARE

Yeshwant Ayurvedic College

drlaxminarhare@gmail.com9822189226

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026